Zynex, Inc., an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, announced the appointment of Steven Dyson as Chief Executive Officer. His employment will begin on August 18, 2025.
Thomas Sandgaard, Founder of Zynex and Chairman of the Board since the company's inception in 1996, will remain actively involved as Chairman and Chair of the Board's Technology Committee.
Steven will operate from the Zynex headquarters in Englewood, Colorado, while maintaining a residence in London, England. He holds a B.A. from Oxford University and a Ph.D. from Cambridge University.
"I am excited to step back from day-to-day operations and continue contributing as Chairman," said Thomas Sandgaard. "Steven brings deep expertise and a proven track record in the medical sector. His leadership will be instrumental as we refocus our business strategy toward a more optimized payer mix and work to return Zynex to a strong growth trajectory."
Newly appointed CEO Steven Dyson added, "I'm honored to join the Zynex team at this exciting time in the Company's history and to have the opportunity to lead the Company back to a strong growth trajectory. Zynex's strong foundation, built by Thomas over many years, provides an excellent platform to deliver exceptional value for all our stakeholders "
Comments powered by CComment